(0.03%) 5 518.50 points
(0.14%) 39 900 points
(0.06%) 19 763 points
(-0.02%) $81.61
(0.50%) $2.83
(-0.25%) $2 338.50
(0.17%) $29.58
(0.57%) $1 007.50
(0.12%) $0.933
(-0.05%) $10.53
(0.02%) $0.788
(-0.85%) $87.25
-4.12% $ 1.860
Live Chart Being Loaded With Signals
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease...
Stats | |
---|---|
Dzisiejszy wolumen | 40 114 |
Średni wolumen | 253 743 |
Kapitalizacja rynkowa | 4.29M |
EPS | $-4.58 ( Q1 | 2024-05-15 ) |
Następna data zysków | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.200 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0280 (1.51%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-23 | Pharmacyte Biotech, Inc. | Sell | 3 854 626 | Series G Convertible Preferred Stock |
2024-05-23 | Pharmacyte Biotech, Inc. | Sell | 3 854 626 | Warrants |
2024-04-08 | Glass Mitchell | Buy | 0 | |
2023-08-24 | Rivard Paul | Buy | 150 000 | Common stock |
2023-08-17 | Rivard Paul | Buy | 25 000 | Common stock |
INSIDER POWER |
---|
-71.01 |
Last 83 transactions |
Buy: 8 607 737 | Sell: 8 242 027 |
MyMD Pharmaceuticals, Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
AGRI | 0.947 |
LGVN | 0.946 |
TBLT | 0.942 |
VRM | 0.94 |
FFIE | 0.937 |
ESCA | 0.936 |
BPRN | 0.933 |
RSLS | 0.933 |
ACON | 0.932 |
PLL | 0.932 |
10 Najbardziej negatywne korelacje | |
---|---|
KBWP | -0.942 |
ADTH | -0.94 |
FLXS | -0.924 |
SILK | -0.916 |
BUFF | -0.916 |
DXJS | -0.916 |
EWJV | -0.914 |
NVDA | -0.914 |
NTNX | -0.913 |
PRAX | -0.911 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MyMD Pharmaceuticals, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-2.59 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-2.59 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-11.68 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.850 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
MyMD Pharmaceuticals,
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej